" /> Skip to main content
CIN- L67120MH1995PLC084899
  

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID



Aptus Pharma - Board Meeting Outcome for Outcome Of Board Meeting Held On 20.10.2026 Along With Financial Results For Half Ye

Source By

Dion Global

20 Oct 2026

Pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure\r\nRequirements) Regulations, 2015, we wish to inform you that the Board of Directors of the\r\nCompany at its meeting held today, i.e., Tuesday, October 20, 2026, inter alia, considered and\r\napproved the following:\r\nThe Unaudited Financial Results of the Company for the half year ended September 30, 2026,\r\nalong with the Limited Review Report issued by the Statutory Auditors, have been approved\r\nby the Board of Directors. The copy of the same is enclosed herewith as Annexure.\r\nFurther, in accordance with the Securities and Exchange Board of India (Prohibition of Insider\r\nTrading) Regulations, 2015 and Company's Code of conduct for Prohibition of Insider Trading,\r\nthe \Trading Window\ for trading in the shares of the Company will open from 23 October,\r\n2026. for the Designated Persons and their immediate relatives.\r\n